Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma
- 23 October 2007
- journal article
- letter
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 87 (3), 253-254
- https://doi.org/10.1007/s00277-007-0401-8
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Bortezomib: an effective agent in extramedullary disease in multiple myelomaEuropean Journal of Haematology, 2006
- Successful treatment of lymph node extramedullary plasmacytoma with bortezomibAnnals of Hematology, 2006
- Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.Journal of Clinical Oncology, 1994